RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 151 filers reported holding RA PHARMACEUTICALS INC in Q1 2020. The put-call ratio across all filers is 16.18 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $936,291,000 | +387.7% | 19,502 | +376.7% | 0.00% | – |
| Q4 2019 | $191,991,000 | +62.3% | 4,091 | -18.2% | 0.00% | – |
| Q3 2019 | $118,321,000 | +87.2% | 5,003 | +138.0% | 0.00% | – |
| Q2 2019 | $63,207,000 | -28.0% | 2,102 | -46.3% | 0.00% | – |
| Q1 2019 | $87,741,000 | +213.7% | 3,917 | +153.4% | 0.00% | – |
| Q3 2018 | $27,967,000 | +106.8% | 1,546 | +13.8% | 0.00% | – |
| Q2 2018 | $13,522,000 | -38.9% | 1,359 | -67.4% | 0.00% | – |
| Q1 2018 | $22,132,000 | +3.4% | 4,168 | +65.5% | 0.00% | – |
| Q4 2017 | $21,412,000 | +19.6% | 2,519 | +105.5% | 0.00% | – |
| Q3 2017 | $17,900,000 | -25.9% | 1,226 | -4.9% | 0.00% | – |
| Q2 2017 | $24,156,000 | +1521.2% | 1,289 | +1741.4% | 0.00% | – |
| Q1 2017 | $1,490,000 | – | 70 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|